Gene editing companies develop technologies that make targeted changes to DNA sequences within cells and organisms. These tools support biological research, therapeutic development, cell engineering, agriculture and the creation of improved production strains.
This category includes companies working on:
Browse 60 UK gene editing companies below.
Gene editing platform restoring disease resistance in crop species
Resurrect Bio is a plant biotechnology company developing disease-resistant crops through a proprietary gene editing platform. Using computational biology and high-throughput plant screening, the company identifies and restores native resistance genes that have been suppressed by pathogens or lost through selective…
End-to-end viral vector design, production and gene delivery
VectorBuilder is a global provider of gene delivery solutions offering an integrated suite of research products, custom services, and clinical-grade manufacturing. The company's platform spans viral vector design and cloning, packaging of lentiviral, AAV, and adenoviral vectors, plasmid and IVT mRNA manufacture,…
Cell and gene therapy CDMO with integrated consultancy services
eXmoor Pharma is a Bristol-based contract development and manufacturing organisation specialising in cell and gene therapies. Operating from a 65,000 sq ft MHRA-licensed GMP facility, the company provides services spanning process development, viral vector and cell therapy manufacture, fill and finish, and QP release.…
Graph AI platform for crop gene target discovery and precision breeding
Biographica is a London agbiotech developing a graph machine learning platform to identify and validate gene editing targets for crop improvement. The platform integrates genomic, transcriptomic, and scientific literature data within knowledge graphs, combining in silico modelling with in vivo validation at Rothamsted…
Global cell and gene therapy CDMO
Minaris Advanced Therapies is a company providing contract development, manufacturing and testing services across the cell and gene therapy lifecycle. Its UK operations originate from the former Oxgene business, contributing proprietary AAV and lentiviral manufacturing technologies. In December 2025 the company…
CRISPR-engineered tumour-infiltrating lymphocyte therapy
Intima Bioscience is a clinical-stage biotechnology company developing CRISPR gene-edited tumour-infiltrating lymphocyte therapies for solid tumours. Its platform targets CISH, an intracellular immune checkpoint that suppresses T cell activity against tumours; CRISPR knockout of CISH in patient-derived TILs enhances…
Institute researching molecular plant microbe interactions and disease resistance
The Sainsbury Laboratory is a research institute studying molecular plant microbe interactions to improve plant health and reduce crop losses. The Laboratory investigates innate immune recognition in plants and the engineering of novel immune receptors in crops. Its work includes developing genome editing tools to…
AI-driven platform engineering better crop varieties
Wild Bioscience is an agricultural biotechnology company developing next-generation crop varieties using a platform that combines evolutionary biology with machine learning. By mining genetic variation in wild plant relatives, the company identifies and designs gene edits targeting traits including nitrogen use…
Gene-edited crop traits for yield under climate stress
ALORA is an agricultural biotechnology company developing gene-edited crop traits that redirect plant energy from stress defence to yield. Using multiplex gene editing, the company targets regulatory pathways controlling how plants respond to heat, salinity, and drought, aiming to increase productivity across growing…
Animal genetics company applying genomics and gene editing to livestock
Genus plc specialises in the genetic improvement of livestock through genomic selection and gene editing. Its commercial divisions supply semen and embryos from elite cattle and genetically superior breeding pigs to producers globally. Its R&D programme applies CRISPR-based precision breeding to improve disease…
Organelle engineering platform developing novel crop traits for agriculture
Cytotrait is a biotechnology company developing novel traits for food and agricultural crops. Its MOSS platform introduces genes and gene edits into plant organelles, including chloroplasts and mitochondria, enabling rapid homoplasmy across the plant. The approach aims to improve yield, resilience, disease resistance…
TCR-based bispecific therapeutics for cancer and autoimmune disease
T-Therapeutics is a biotechnology company developing T cell receptor-based therapeutics for cancer and autoimmune disease. Using a humanised TCR mouse platform to generate high-affinity, antigen-specific human T cell receptors, the company engineers bispecific molecules that redirect a patient's own T cells to…
Programmable iPSC cell therapies for cancer and autoimmunity
Xap Therapeutics is a Cambridge-based biotechnology company developing a synthetic biology platform for next-generation cell therapeutics. The company applies CRISPR technology to engineer induced pluripotent stem cells (iPSCs) into a universal "chassis" cell that can be functionalised with engineered receptors and…
AI-driven AAV capsid engineering for next-generation gene therapy
Lir Therapeutics is an early-stage biotechnology company redesigning adeno-associated virus capsids for gene therapy using an AI-first platform. Its platform integrates high-throughput experimental data generation with machine learning models trained on structural, functional and immunogenicity representations of…
Early phase clinical trial CRO based at London Bridge
Richmond Pharmacology is a contract research organisation specialising in early phase and first-in-human clinical trials for pharmaceutical and biotech companies. Operating from hospital-adjacent facilities at London Bridge and St George's University London, the company has conducted over 20% of all UK Phase I studies…
Genomics-led breeding of climate-resilient food crops
Viridian Seeds is an agricultural biotechnology company developing climate-resilient crop varieties using genomics-assisted trait discovery and plant breeding. Its research focuses on legumes, including chickpeas, lentils and soybeans, and improved tomatoes for sustainable food production. The company reports an…
Human iPSC-based safety and genotoxicity testing for gene therapy vectors
TestAVec is a provider of in vitro safety testing services for gene therapy and viral vector products, serving academic researchers and industry developers. The company's human stem cell based platform assesses vector-induced genotoxicity, evaluates patients' DNA repair capacity ahead of radiation or chemotherapy, and…
Agri-tech sensors, machine learning and gene editing for fresh produce
B-Hive Innovations is an agri-tech research and development company that designs sensor systems, machine learning tools, and hardware solutions for the fresh produce industry. Working with farmers, packers, and supply chain partners, the company addresses challenges including non-destructive crop quality assessment,…
GMP lentiviral and retroviral vector design and manufacture for CGT
ViroCell Biologics is a specialist contract development and manufacturing organisation providing GMP design and manufacture of lentiviral and retroviral vectors for cell and gene therapy clinical trials. The company serves academic and corporate innovators developing CAR-T therapies, rare disease gene therapies, and…
Academic-industry translational research institute
The Milner Therapeutics Institute is a University of Cambridge biomedical research institute established to bridge academic science and pharmaceutical drug discovery. Founded in 2015 and based at the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus, it operates both an in-house research programme and…